Disclosed is the use of a) at least one isoxazoline active agent of Formula (I) which is preferably afoxolaner or an analogue thereof and b) a pharmaceutically acceptable carrier, wherein the pharmaceutically acceptable carrier comprises one or more surfactants, selected from a polyethylene glycol stearate and a polyethylene glycol hydroxystearate, for the manufacture of a soft chewable veterinary composition.